| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |